Stocks and Investing Stocks and Investing
Tue, June 28, 2022
Mon, June 27, 2022
Fri, June 24, 2022
Thu, June 23, 2022

Paul Matteis Downgraded (ATHA) to Hold and Decreased Target to $5 on, Jun 23rd, 2022


Published on 2024-10-27 21:36:23 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Stifel, Downgraded "Athira Pharma, Inc." (ATHA) to Hold and Decreased Target from $36 to $5 on, Jun 23rd, 2022.

Paul has made no other calls on ATHA in the last 4 months.



There are 2 other peers that have a rating on ATHA. Out of the 2 peers that are also analyzing ATHA, 0 agree with Paul's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Paul


  • Thomas Shrader of "BTIG" Initiated at Strong Buy and Held Target at $33 on, Tuesday, May 10th, 2022
  • Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $33 on, Thursday, April 21st, 2022